PAIN THERAPEUTICS FILES $150 MLN MIXED SHELF

Pain Therapeutics Inc. may periodically sell up to $150 million in debt, common stock, preferred stock, depositary shares and warrants, according to a regulatory filing on Friday. The South San Francisco, California-based biopharmaceuticals company said it plans to use the proceeds for general corporate purposes including acquisitions, and working capital, according to the filing with the U.S. Securities and Exchange Commission.

Reuters (http://today.reuters.com/investing/financeArticle.aspx?type=newIssuesNews&storyID=2005-08-26T205641Z_01_WAT003707_RTRIDST_0_HEALTH-PAINTHERAPEUTICS-SHELF-URGENT.XML)